Jason Lamar Aldred MD

PubMed

• Efficacy and Safety of Foslevodopa/Foscarbidopa Monotherapy in Patients with Parkinson's Disease.
  Jason Aldred, Manon Bouchard, Juan Carlos Martínez-Castrillo, Michael J Soileau, Amy M Spiegel
  Movement Disorders Clinical Practice. 2025-07-30
• Sustained Therapeutic Benefits Using Image-Guided Programming at Activation of Deep Brain Stimulation for Parkinson's Disease.
  Jason L Aldred, Theresa Zesiewicz, Michael S Okun, Adolfo Ramirez-Zamora, Okeanis E Vaou
  Movement Disorders Clinical Practice. 2025-06-05
• 1 citations
  Patients' experience with and perspectives on long-term use of continuous subcutaneous infusion of foslevodopa/foscarbidopa in Parkinson's disease.
  Michael Soileau, Rajeev Kumar, Ashwini Parab, Triza Brion, Kailee White
  Journal of Neurology. 2025-05-22

Journal Articles

• The past, present, and future of telemedicine for Parkinson's disease  
  Achey, M, Aldred, JL et al., Movement Disoders, 6/29/2014
• Are high doses of carbidopa a concern? A randomized, clinical trial in Parkinson's disease  
  Aldred JL, Brod LS, Nutt JG, Movement Disorders, 5/2012

Books/Book Chapters

• Encyclopedia of Movement Disorders 
  Chapter: Levodopa. 
  Page 132 - 137Aldred, J. and Nutt, J.Editors: K. Kompoliti and L. Verhagen.Associated Press2010

Abstracts/Posters

• Levodopa-Carbidopa Intestinal Gel for the Treatment of Motor Fluctuations and Dyskinesia in Patients with Advanced Parkinson's Disease in a Real World Setting: Results...
  Standaert, D, Aldred, J et. al, XXIV World Congress of Neurology, Dubai, UAE, 7/2019
• Open Label Study of Pimavanserin in Patients with Comorbid Parkinson's Disease and Depression.
  Guskey, M, Aldred, J et al., Neuroscience Education Institute Congress, Colorado Springs, CO, USA, 2019
• Medication Use and In-Hospital Complications for Patients with Parkinson’s disease: A Retrospective Review. (Poster Presentation)
  Kerndt, T, Aldred J, et al., World Parkinson Congress, Montreal, Canada, 1/1/2013
• Hyperkinetic shoulder movement disorder associated with Ehlers-Danlos Syndrome. (Abstract)
  American Academy of Neurology Meeting, 1/1/2009
• Writer’s cramp, hemidystonia and ataxia secondary to pontomedullary tumor. (Abstract)
  Movement Disorders Society International Congress, 1/1/2008
• Efficacy of donepezil for tic reduction. (Abstract)
  Movement Disorders Society International Congress, 1/1/2008
• Join now to see all

Lectures

• DBS Update 
  La Crosse, WI - 1/1/2013
• Advances in Parkinson’s Care and Treatment 
  Wisconsin Dells, WI - 1/1/2013
• “Patient with Limited Response to Previous Toxin Therapies” 
  La Crosse, WI - 1/1/2012
• “Update on Dystonia and Movement Disorders” 
  La Crosse, WI - 1/1/2012
• Understanding Gait in Parkinson’s Disease 
  1/1/2012
• Second Annual Parkinson’s Symposium 
  La Crosse, WI - 1/1/2012
• Movement Disorders Presentation 
  1/1/2011
• Parkinson’s Disease Update 
  Black River Falls, WI - 1/1/2011
• First Annual Parkinson’s Symposium 
  La Crosse, WI - 1/1/2011
• Parkinson’s Disease Research Update 
  1/1/2010
• “Cervical Dystonia” 
  1/1/2010
• “Movement Disorders”, Grand Rounds 
  Gundersen Lutheran Medical Center - 1/1/2010
• “Early Diagnosis and Treatment of Parkinson’s Disease - A Continuing Pursuit” 
  Gundersen Lutheran Medical Center - 1/1/2010
• “Shaking Up Parkinson’s Disease” 
  Tomah, WI - 1/1/2010
• Parkinson’s Disease Update 
  Decorah, IA - 1/1/2010
• Essential Tremor Patient Symposium 
  Gundersen Lutheran Medical Center, La Crosse, WI - 1/1/2010
• Research Update on Parkinson’s Disease 
  1/1/2008
• Non-Motor Features of Parkinson’s Disease, presentation 
  1/1/2007
• Spinal Cord Disease, presentation 
  1/1/2006
• Update of Parkinson’s Disease Research for the Corvallis 
  1/1/2006
• Neurotoxicology and Movement Disorders, presentation 
  1/1/2005
• Join now to see all

Other

• Concept and Development of Department of Neurology and Residency Program Website 
  Aldred JL, Oregon Health and Science Neurology Department
  1/1/2005